Home > Insider Trading > Adaptimmune Therapeutics Plc

Adaptimmune Therapeutics Plc (ADAP)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q3 2024 Earnings Call Transcript

Operator: Hello and welcome to the Adaptimmune Therapeutics Third Quarter 2024 Results Conference Call. As a reminder, all participants are in listen-only mode, and the conference is being recorded.

Keep Reading →

November 15th, 2024 - News Transcripts

Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q2 2024 Earnings Call Transcript

Operator: Good day and welcome to the Adaptimmune Second Quarter 2024 Conference Call. All participants will be in a listen-only mode.

Keep Reading →

August 13th, 2024 - News Transcripts

Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q1 2024 Earnings Call Transcript

Operator: Good morning, ladies and gentlemen, and welcome to the Adaptimmune Q1 2024 Financial and Business Update Conference Call. I would now like to turn the meeting over to Ms. Juli Miller.

Keep Reading →

May 16th, 2024 - News Transcripts

Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q4 2023 Earnings Call Transcript

Juli Miller: Good morning, thank you for joining us.

Keep Reading →

March 7th, 2024 - News Transcripts

15 Top Performing European Stocks So Far in 2024

In this piece, we will take a look at the 15 top performing European stocks so far in 2024.

Keep Reading →

February 16th, 2024 - News

Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q3 2023 Earnings Call Transcript

Operator: Good morning, ladies and gentlemen, and welcome to the Adaptimmune’s Q3 Financial and Business Update Conference Call. I would now like to turn the meeting over to Ms. Juli Miller.

Keep Reading →

November 13th, 2023 - News Transcripts

Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q2 2023 Earnings Call Transcript

Operator: Good morning, ladies and gentlemen and welcome to Adaptimmune’s Q2 Financial and Business Update Conference Call. I would now like to turn the meeting call over to Ms. Juli Miller.

Keep Reading →

August 13th, 2023 - News Transcripts

Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q1 2023 Earnings Call Transcript

Juli Miller: Good morning, and welcome to Adaptimmune's conference call to discuss our first quarter 2023 financial results and business updates.

Keep Reading →

May 17th, 2023 - News Transcripts

Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q4 2022 Earnings Call Transcript

Operator: Welcome to Adaptimmune and TCR2 joint webcast to discuss their strategic combination announced earlier this morning.

Keep Reading →

March 8th, 2023 - News Transcripts

5 High Growth UK Stocks to Buy

Adaptimmune Therapeutics plc (NASDAQ:ADAP) is a biotechnology firm that develops tumor and cancer treatments. Some cancers that the firm is taking aim at include those of the lungs, head, and neck.

Keep Reading →

March 1st, 2023 - Hedge Funds News